FDA Adverse Event Malfunction Summary report: N

INCEPTA

MDR report key: 2914317 · Received January 14, 2013

Report

Report Number
2124215-2013-00914
Event Type
Malfunction
Date Received
January 14, 2013
Date of Event
December 3, 2012
Report Date
December 18, 2012
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT DURING A CHANGE-OUT PROCEDURE HIGH, OUT-OF-RANGE (OOR), SHOCK LEAD IMPEDANCES WERE OBTAINED WHEN PAINLESS COMMANDED IMPEDANCE TESTING WAS DONE ON THIS RIGHT VENTRICULAR (RV) LEAD AND CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) SYSTEM. READINGS OF >125 OHMS IN THE TRIAD CONFIGURATION WERE OBTAINED, AND READINGS OF 119 AND >125 OHMS WERE OBSERVED WHEN THE RV COIL TO CAN AND COLD CAN MEASUREMENTS WERE TAKEN (THOUGH IT IS NOT KNOWN WHICH CONFIGURATION HAD WHAT READING). DEFIBRILLATION THRESHOLD (DFT) TESTING WAS DONE IN THE TRIAD CONFIGURATION AND AT 31J THE IMPEDANCE WAS 53 OHMS. THE FIELD REPRESENTATIVE CONSULTED WITH BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) AND POTENTIAL REASONS FOR THE VARYING MEASUREMENTS WERE PROVIDED. AT THIS TIME, BOTH THIS RV LEAD AND CRT-D REMAIN IN SERVICE AND THE PROGRAMMED SHOCK CONFIGURATION REMAINS TRIAD. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
19682 INCEPTA IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND N161

Patients

Seq Age Sex Outcome Treatment
1 59 YR N161| 4549| 4470| 0185| H217